| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 210 | 2023 | 5369 | 7.270 |
Why?
|
| Pancreatitis | 139 | 2015 | 1097 | 5.620 |
Why?
|
| Pancreatectomy | 72 | 2021 | 811 | 5.370 |
Why?
|
| Carcinoma, Pancreatic Ductal | 68 | 2023 | 1727 | 4.480 |
Why?
|
| Pancreas | 110 | 2023 | 1691 | 3.890 |
Why?
|
| Pancreaticoduodenectomy | 39 | 2021 | 509 | 3.410 |
Why?
|
| General Surgery | 33 | 2015 | 1692 | 3.220 |
Why?
|
| Pancreatic Diseases | 39 | 2017 | 344 | 2.440 |
Why?
|
| Pancreatic Ducts | 38 | 2022 | 329 | 2.290 |
Why?
|
| Pancreatic Cyst | 32 | 2020 | 367 | 2.240 |
Why?
|
| Adenocarcinoma, Mucinous | 29 | 2021 | 517 | 1.940 |
Why?
|
| Pancreatitis, Acute Necrotizing | 18 | 2014 | 173 | 1.720 |
Why?
|
| Adenocarcinoma | 47 | 2023 | 6345 | 1.490 |
Why?
|
| Trypsinogen | 20 | 1999 | 84 | 1.470 |
Why?
|
| Carcinoma, Papillary | 19 | 2017 | 785 | 1.470 |
Why?
|
| Amylases | 42 | 2015 | 171 | 1.290 |
Why?
|
| Drainage | 28 | 2019 | 1156 | 1.090 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 7 | 2023 | 194 | 1.000 |
Why?
|
| Mass Casualty Incidents | 3 | 2017 | 179 | 1.000 |
Why?
|
| Pancreatic Fistula | 13 | 2019 | 148 | 0.980 |
Why?
|
| Firearms | 3 | 2018 | 626 | 0.980 |
Why?
|
| Cystadenoma, Serous | 12 | 2021 | 100 | 0.910 |
Why?
|
| CA-19-9 Antigen | 5 | 2022 | 106 | 0.880 |
Why?
|
| Debridement | 9 | 2014 | 493 | 0.860 |
Why?
|
| Common Bile Duct Neoplasms | 11 | 2017 | 120 | 0.860 |
Why?
|
| Pancreatic Pseudocyst | 19 | 2000 | 110 | 0.830 |
Why?
|
| Ampulla of Vater | 13 | 2017 | 149 | 0.810 |
Why?
|
| Cystadenoma | 11 | 2005 | 79 | 0.790 |
Why?
|
| Acute Disease | 86 | 2015 | 7236 | 0.750 |
Why?
|
| Laparoscopy | 17 | 2018 | 2030 | 0.700 |
Why?
|
| Pancreatitis, Chronic | 6 | 2017 | 288 | 0.700 |
Why?
|
| Wounds, Gunshot | 2 | 2018 | 582 | 0.690 |
Why?
|
| Spleen | 6 | 2019 | 2286 | 0.660 |
Why?
|
| Societies, Medical | 7 | 2015 | 3901 | 0.650 |
Why?
|
| Humans | 471 | 2023 | 760740 | 0.640 |
Why?
|
| Postoperative Complications | 47 | 2019 | 15609 | 0.610 |
Why?
|
| Cystadenoma, Mucinous | 6 | 2012 | 62 | 0.610 |
Why?
|
| Periodicals as Topic | 4 | 2020 | 1463 | 0.610 |
Why?
|
| Editorial Policies | 3 | 2020 | 458 | 0.600 |
Why?
|
| Lobbying | 2 | 2008 | 32 | 0.600 |
Why?
|
| Neuroendocrine Tumors | 10 | 2019 | 641 | 0.580 |
Why?
|
| Cystadenocarcinoma | 8 | 2005 | 54 | 0.560 |
Why?
|
| Survival Rate | 47 | 2023 | 12719 | 0.560 |
Why?
|
| Hospitals, General | 8 | 2017 | 798 | 0.560 |
Why?
|
| Male | 312 | 2023 | 360402 | 0.550 |
Why?
|
| Consensus Development Conferences as Topic | 2 | 2015 | 167 | 0.550 |
Why?
|
| Cystadenocarcinoma, Mucinous | 10 | 2009 | 50 | 0.530 |
Why?
|
| Hepatectomy | 5 | 2017 | 557 | 0.530 |
Why?
|
| Oligopeptides | 14 | 2001 | 1185 | 0.520 |
Why?
|
| Terminology as Topic | 5 | 2014 | 1528 | 0.520 |
Why?
|
| Portal Vein | 11 | 2023 | 431 | 0.520 |
Why?
|
| Hemostatic Techniques | 1 | 2017 | 111 | 0.520 |
Why?
|
| Neoplasm Staging | 32 | 2020 | 11118 | 0.510 |
Why?
|
| Aged | 193 | 2022 | 169092 | 0.500 |
Why?
|
| Middle Aged | 208 | 2022 | 220603 | 0.480 |
Why?
|
| Angiography | 10 | 2011 | 1595 | 0.460 |
Why?
|
| Rats | 72 | 2006 | 23716 | 0.460 |
Why?
|
| Reflex, Stretch | 1 | 2013 | 23 | 0.450 |
Why?
|
| Wit and Humor as Topic | 2 | 2011 | 31 | 0.450 |
Why?
|
| Community Networks | 1 | 2015 | 201 | 0.440 |
Why?
|
| Aneurysm, False | 2 | 2011 | 255 | 0.440 |
Why?
|
| Female | 255 | 2023 | 392203 | 0.440 |
Why?
|
| Neoplastic Cells, Circulating | 5 | 2017 | 943 | 0.430 |
Why?
|
| Surgical Procedures, Operative | 6 | 2018 | 1924 | 0.430 |
Why?
|
| Workload | 5 | 2006 | 844 | 0.420 |
Why?
|
| Correspondence as Topic | 1 | 2012 | 34 | 0.410 |
Why?
|
| Internship and Residency | 12 | 2013 | 5878 | 0.410 |
Why?
|
| Abscess | 13 | 1997 | 606 | 0.410 |
Why?
|
| Pylorus | 3 | 2003 | 86 | 0.400 |
Why?
|
| Fellowships and Scholarships | 2 | 2020 | 1116 | 0.400 |
Why?
|
| Rats, Sprague-Dawley | 41 | 2006 | 8165 | 0.400 |
Why?
|
| Health Care Costs | 5 | 2014 | 3238 | 0.400 |
Why?
|
| Aged, 80 and over | 73 | 2020 | 58919 | 0.390 |
Why?
|
| Holidays | 1 | 2011 | 40 | 0.390 |
Why?
|
| Education, Medical, Graduate | 6 | 2020 | 2373 | 0.390 |
Why?
|
| Bacterial Infections | 9 | 2008 | 1389 | 0.380 |
Why?
|
| History, 19th Century | 5 | 2016 | 718 | 0.370 |
Why?
|
| Esophageal and Gastric Varices | 4 | 2011 | 208 | 0.370 |
Why?
|
| Anatomy | 1 | 2012 | 126 | 0.370 |
Why?
|
| Necrosis | 28 | 1996 | 1610 | 0.360 |
Why?
|
| Famous Persons | 1 | 2011 | 109 | 0.360 |
Why?
|
| Viscera | 1 | 2011 | 138 | 0.360 |
Why?
|
| Pancreas, Exocrine | 4 | 2007 | 48 | 0.350 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 14 | 2009 | 507 | 0.350 |
Why?
|
| Conflict of Interest | 10 | 2002 | 554 | 0.350 |
Why?
|
| Patient Preference | 1 | 2018 | 925 | 0.350 |
Why?
|
| Retrospective Studies | 83 | 2023 | 80583 | 0.350 |
Why?
|
| Video-Assisted Surgery | 1 | 2010 | 51 | 0.340 |
Why?
|
| Prognosis | 47 | 2023 | 29601 | 0.340 |
Why?
|
| Endosonography | 10 | 2011 | 608 | 0.340 |
Why?
|
| Publishing | 11 | 2006 | 832 | 0.340 |
Why?
|
| History, 20th Century | 8 | 2014 | 2764 | 0.330 |
Why?
|
| Authorship | 12 | 2006 | 284 | 0.320 |
Why?
|
| Neoadjuvant Therapy | 12 | 2023 | 2827 | 0.320 |
Why?
|
| Emergency Medical Services | 3 | 2017 | 1921 | 0.310 |
Why?
|
| Patient Participation | 1 | 2018 | 1443 | 0.310 |
Why?
|
| Liver Failure | 1 | 2011 | 250 | 0.310 |
Why?
|
| Physician-Patient Relations | 5 | 2015 | 3239 | 0.310 |
Why?
|
| Cholestasis | 10 | 2019 | 378 | 0.300 |
Why?
|
| Adult | 141 | 2022 | 220995 | 0.300 |
Why?
|
| Mucins | 4 | 2009 | 568 | 0.290 |
Why?
|
| Hypercalcemia | 3 | 1995 | 423 | 0.290 |
Why?
|
| Neutrophils | 6 | 2011 | 3763 | 0.290 |
Why?
|
| Adenoma | 9 | 2017 | 2159 | 0.290 |
Why?
|
| Splenectomy | 6 | 2019 | 389 | 0.290 |
Why?
|
| Survival Analysis | 24 | 2021 | 10072 | 0.290 |
Why?
|
| Jejunum | 14 | 1997 | 472 | 0.290 |
Why?
|
| United States | 36 | 2021 | 72292 | 0.290 |
Why?
|
| Massachusetts | 19 | 2019 | 8835 | 0.280 |
Why?
|
| Fluorouracil | 10 | 2023 | 1642 | 0.280 |
Why?
|
| Gastrectomy | 5 | 2011 | 671 | 0.280 |
Why?
|
| Teaching Rounds | 1 | 2011 | 276 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 47 | 2019 | 20556 | 0.280 |
Why?
|
| Pancreaticojejunostomy | 3 | 2011 | 26 | 0.280 |
Why?
|
| Diagnosis, Differential | 48 | 2011 | 12966 | 0.280 |
Why?
|
| Lymph Nodes | 8 | 2020 | 3461 | 0.280 |
Why?
|
| Preoperative Care | 11 | 2019 | 2242 | 0.280 |
Why?
|
| Biliary Tract Diseases | 6 | 1993 | 159 | 0.280 |
Why?
|
| Plagiarism | 1 | 2006 | 22 | 0.270 |
Why?
|
| Acetamides | 2 | 2020 | 256 | 0.270 |
Why?
|
| Face | 1 | 2012 | 1026 | 0.270 |
Why?
|
| Lawyers | 1 | 2006 | 38 | 0.270 |
Why?
|
| Internet | 2 | 2011 | 3094 | 0.270 |
Why?
|
| Rats, Wistar | 12 | 2004 | 1848 | 0.270 |
Why?
|
| Azepines | 2 | 2020 | 329 | 0.270 |
Why?
|
| Isoenzymes | 12 | 1988 | 1687 | 0.270 |
Why?
|
| Glycodeoxycholic Acid | 11 | 1999 | 23 | 0.260 |
Why?
|
| Neoplasm Invasiveness | 17 | 2021 | 3593 | 0.260 |
Why?
|
| Phenylalanine | 3 | 2002 | 365 | 0.260 |
Why?
|
| Surgery Department, Hospital | 2 | 2005 | 176 | 0.260 |
Why?
|
| Disease Models, Animal | 25 | 2016 | 18220 | 0.260 |
Why?
|
| Music Therapy | 3 | 2013 | 110 | 0.260 |
Why?
|
| Education, Medical | 5 | 2012 | 1725 | 0.260 |
Why?
|
| Scientific Misconduct | 1 | 2006 | 74 | 0.250 |
Why?
|
| Adenoma, Islet Cell | 6 | 1997 | 72 | 0.250 |
Why?
|
| Ethanol | 5 | 2002 | 1320 | 0.250 |
Why?
|
| Digestive System Surgical Procedures | 4 | 2010 | 571 | 0.250 |
Why?
|
| Trypsin | 6 | 2005 | 495 | 0.250 |
Why?
|
| Neoplasm Recurrence, Local | 15 | 2020 | 9277 | 0.250 |
Why?
|
| Work Schedule Tolerance | 2 | 2006 | 552 | 0.240 |
Why?
|
| Stomach | 7 | 2010 | 696 | 0.240 |
Why?
|
| Haemophilus Vaccines | 1 | 2005 | 71 | 0.240 |
Why?
|
| Imipenem | 4 | 2000 | 37 | 0.240 |
Why?
|
| Public Health | 1 | 2018 | 2671 | 0.240 |
Why?
|
| Tetanus Toxoid | 1 | 2005 | 188 | 0.240 |
Why?
|
| Animals | 100 | 2020 | 168202 | 0.240 |
Why?
|
| Sex Characteristics | 2 | 2014 | 2637 | 0.240 |
Why?
|
| Hedgehog Proteins | 5 | 2020 | 768 | 0.230 |
Why?
|
| Radiography, Interventional | 2 | 2011 | 1120 | 0.230 |
Why?
|
| Leukocytes | 5 | 2004 | 2024 | 0.230 |
Why?
|
| Health Care Reform | 3 | 2015 | 1247 | 0.230 |
Why?
|
| Quality of Health Care | 4 | 2021 | 4325 | 0.230 |
Why?
|
| Bile | 3 | 2021 | 298 | 0.230 |
Why?
|
| Publications | 2 | 2010 | 194 | 0.230 |
Why?
|
| Genes, ras | 6 | 2003 | 654 | 0.230 |
Why?
|
| Tumor Microenvironment | 5 | 2021 | 3868 | 0.230 |
Why?
|
| Cysts | 6 | 2011 | 680 | 0.230 |
Why?
|
| Expert Testimony | 1 | 2006 | 364 | 0.220 |
Why?
|
| Duodenal Diseases | 5 | 2011 | 99 | 0.220 |
Why?
|
| Nomograms | 1 | 2005 | 230 | 0.220 |
Why?
|
| Patient Advocacy | 1 | 2006 | 360 | 0.220 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2020 | 2821 | 0.220 |
Why?
|
| Embolization, Therapeutic | 3 | 2011 | 1418 | 0.220 |
Why?
|
| Politics | 2 | 2008 | 813 | 0.220 |
Why?
|
| Leucovorin | 4 | 2021 | 643 | 0.220 |
Why?
|
| Ascitic Fluid | 8 | 2000 | 189 | 0.220 |
Why?
|
| Edema | 8 | 1999 | 765 | 0.220 |
Why?
|
| Lymphatic Metastasis | 13 | 2020 | 2913 | 0.220 |
Why?
|
| Follow-Up Studies | 37 | 2021 | 39062 | 0.210 |
Why?
|
| Personnel Turnover | 1 | 2003 | 88 | 0.210 |
Why?
|
| Mesenteric Veins | 6 | 2023 | 86 | 0.210 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3882 | 0.210 |
Why?
|
| Carcinoembryonic Antigen | 7 | 2009 | 335 | 0.210 |
Why?
|
| Computer-Assisted Instruction | 1 | 2006 | 362 | 0.210 |
Why?
|
| Length of Stay | 17 | 2019 | 6418 | 0.210 |
Why?
|
| Duodenal Neoplasms | 4 | 2011 | 114 | 0.200 |
Why?
|
| Teratoma | 1 | 2005 | 404 | 0.200 |
Why?
|
| Intestinal Fistula | 6 | 1985 | 142 | 0.200 |
Why?
|
| Pancreatitis, Alcoholic | 2 | 2002 | 28 | 0.200 |
Why?
|
| Cell Movement | 5 | 2020 | 5201 | 0.200 |
Why?
|
| Kaplan-Meier Estimate | 12 | 2021 | 6473 | 0.200 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 5 | 2016 | 1745 | 0.200 |
Why?
|
| Registries | 4 | 2021 | 8209 | 0.190 |
Why?
|
| Duodenum | 9 | 1996 | 491 | 0.190 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2005 | 333 | 0.190 |
Why?
|
| Personnel Selection | 1 | 2003 | 196 | 0.190 |
Why?
|
| Bile Duct Neoplasms | 6 | 2017 | 606 | 0.190 |
Why?
|
| Gastritis | 4 | 1988 | 199 | 0.190 |
Why?
|
| Splenic Vein | 7 | 2009 | 30 | 0.190 |
Why?
|
| Chemotherapy, Adjuvant | 7 | 2020 | 3514 | 0.190 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 8 | 2023 | 11735 | 0.190 |
Why?
|
| Clinical Trials as Topic | 12 | 2002 | 7995 | 0.190 |
Why?
|
| Caregivers | 3 | 2023 | 2241 | 0.190 |
Why?
|
| Anesthetics, Inhalation | 1 | 2006 | 572 | 0.190 |
Why?
|
| Biopsy, Needle | 10 | 2003 | 1624 | 0.190 |
Why?
|
| Palliative Care | 9 | 2012 | 3593 | 0.190 |
Why?
|
| Pneumococcal Vaccines | 1 | 2005 | 397 | 0.190 |
Why?
|
| Fistula | 3 | 1989 | 212 | 0.190 |
Why?
|
| Crohn Disease | 8 | 2004 | 2279 | 0.190 |
Why?
|
| Wine | 1 | 2001 | 166 | 0.190 |
Why?
|
| Laparotomy | 4 | 2018 | 456 | 0.180 |
Why?
|
| Consensus | 1 | 2011 | 3117 | 0.180 |
Why?
|
| Cholecystectomy | 5 | 2014 | 406 | 0.180 |
Why?
|
| Chronic Disease | 28 | 2009 | 9310 | 0.180 |
Why?
|
| Epithelial Cells | 5 | 2015 | 3672 | 0.180 |
Why?
|
| Bile Reflux | 3 | 1988 | 11 | 0.180 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2004 | 1128 | 0.180 |
Why?
|
| L-Selectin | 1 | 2001 | 211 | 0.180 |
Why?
|
| Plectin | 2 | 2010 | 14 | 0.180 |
Why?
|
| Cholecystectomy, Laparoscopic | 2 | 1993 | 231 | 0.180 |
Why?
|
| Radiopharmaceuticals | 2 | 2002 | 2650 | 0.180 |
Why?
|
| Intraoperative Period | 7 | 2018 | 510 | 0.180 |
Why?
|
| Hemorrhage | 7 | 2018 | 3418 | 0.180 |
Why?
|
| Retirement | 1 | 2021 | 197 | 0.170 |
Why?
|
| Macrophage-1 Antigen | 1 | 2001 | 285 | 0.170 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2011 | 631 | 0.170 |
Why?
|
| Colonic Diseases | 7 | 1985 | 201 | 0.170 |
Why?
|
| Klebsiella Infections | 1 | 2021 | 144 | 0.170 |
Why?
|
| Health Services Accessibility | 5 | 2021 | 5430 | 0.170 |
Why?
|
| Time Factors | 33 | 2021 | 39908 | 0.170 |
Why?
|
| Neoplasm Proteins | 3 | 2020 | 3607 | 0.170 |
Why?
|
| Adenocarcinoma, Papillary | 2 | 2010 | 84 | 0.170 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2003 | 495 | 0.170 |
Why?
|
| Contrast Media | 10 | 2010 | 5305 | 0.160 |
Why?
|
| Deoxycytidine | 3 | 2020 | 878 | 0.160 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1999 | 221 | 0.160 |
Why?
|
| Contract Services | 10 | 2002 | 89 | 0.160 |
Why?
|
| Klebsiella pneumoniae | 1 | 2021 | 249 | 0.160 |
Why?
|
| Enteropeptidase | 4 | 1999 | 10 | 0.160 |
Why?
|
| Pulmonary Alveoli | 1 | 2002 | 652 | 0.160 |
Why?
|
| Cyclosporine | 1 | 2001 | 776 | 0.160 |
Why?
|
| Guidelines as Topic | 1 | 2005 | 1386 | 0.160 |
Why?
|
| Ischemia | 6 | 2005 | 1885 | 0.160 |
Why?
|
| Neoplasms | 7 | 2022 | 22131 | 0.160 |
Why?
|
| Treatment Outcome | 32 | 2020 | 64572 | 0.160 |
Why?
|
| Cholesterol Esters | 2 | 2002 | 73 | 0.160 |
Why?
|
| Thrombosis | 4 | 2023 | 2942 | 0.160 |
Why?
|
| Cholelithiasis | 6 | 2011 | 407 | 0.160 |
Why?
|
| Nitric Oxide | 2 | 1998 | 2135 | 0.160 |
Why?
|
| Gastrinoma | 2 | 2017 | 20 | 0.160 |
Why?
|
| Intestinal Obstruction | 5 | 1996 | 432 | 0.160 |
Why?
|
| Rats, Inbred Strains | 10 | 1992 | 2088 | 0.150 |
Why?
|
| Peroxidase | 7 | 2006 | 610 | 0.150 |
Why?
|
| Peritoneal Neoplasms | 9 | 2000 | 710 | 0.150 |
Why?
|
| Dextrans | 4 | 1996 | 573 | 0.150 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 1998 | 61 | 0.150 |
Why?
|
| Nitric Oxide Donors | 1 | 1998 | 126 | 0.150 |
Why?
|
| Social Responsibility | 1 | 2001 | 385 | 0.150 |
Why?
|
| Quality of Life | 5 | 2023 | 13359 | 0.150 |
Why?
|
| Microcirculation | 13 | 2005 | 1272 | 0.150 |
Why?
|
| Carcinoma, Ductal, Breast | 4 | 2000 | 1084 | 0.150 |
Why?
|
| Models, Biological | 1 | 2014 | 9461 | 0.150 |
Why?
|
| Antineoplastic Agents | 8 | 2020 | 13635 | 0.150 |
Why?
|
| Hypophosphatemia | 1 | 2018 | 92 | 0.150 |
Why?
|
| Protease Inhibitors | 4 | 2002 | 753 | 0.150 |
Why?
|
| Quinolones | 1 | 2021 | 378 | 0.150 |
Why?
|
| Palmitic Acids | 1 | 1997 | 53 | 0.150 |
Why?
|
| Diabetes Mellitus | 3 | 2023 | 5838 | 0.150 |
Why?
|
| Bile Ducts | 3 | 1992 | 282 | 0.150 |
Why?
|
| Common Bile Duct Diseases | 6 | 1985 | 36 | 0.150 |
Why?
|
| Fluid Therapy | 3 | 2019 | 577 | 0.150 |
Why?
|
| Gastric Bypass | 1 | 2006 | 818 | 0.140 |
Why?
|
| Carcinoma, Acinar Cell | 3 | 2017 | 62 | 0.140 |
Why?
|
| History, 21st Century | 4 | 2012 | 1566 | 0.140 |
Why?
|
| Gastric Fistula | 2 | 1989 | 73 | 0.140 |
Why?
|
| Cancer Care Facilities | 1 | 2020 | 422 | 0.140 |
Why?
|
| Task Performance and Analysis | 2 | 2012 | 763 | 0.140 |
Why?
|
| Cell Biology | 3 | 2014 | 90 | 0.140 |
Why?
|
| Intestine, Small | 5 | 2016 | 1207 | 0.140 |
Why?
|
| Alkalies | 3 | 1988 | 44 | 0.140 |
Why?
|
| Ribonucleases | 4 | 1984 | 277 | 0.140 |
Why?
|
| Accreditation | 1 | 2020 | 473 | 0.140 |
Why?
|
| Diagnostic Errors | 6 | 1998 | 1265 | 0.140 |
Why?
|
| Recurrence | 14 | 2011 | 8426 | 0.130 |
Why?
|
| Precancerous Conditions | 3 | 2015 | 982 | 0.130 |
Why?
|
| Intraoperative Care | 2 | 2019 | 767 | 0.130 |
Why?
|
| Lung Diseases | 3 | 2002 | 1909 | 0.130 |
Why?
|
| Hemodilution | 2 | 1995 | 120 | 0.130 |
Why?
|
| Peptides | 7 | 2015 | 4354 | 0.130 |
Why?
|
| Ultrasonography | 17 | 2011 | 5965 | 0.130 |
Why?
|
| Medical Staff, Hospital | 2 | 2011 | 601 | 0.130 |
Why?
|
| Disease-Free Survival | 7 | 2021 | 6807 | 0.130 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2020 | 829 | 0.130 |
Why?
|
| Prospective Studies | 27 | 2023 | 54364 | 0.130 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2018 | 173 | 0.130 |
Why?
|
| Candidiasis | 2 | 1993 | 365 | 0.130 |
Why?
|
| Liver Neoplasms | 13 | 2012 | 4309 | 0.130 |
Why?
|
| Mitotic Index | 1 | 2016 | 162 | 0.130 |
Why?
|
| Calcium | 7 | 1997 | 5717 | 0.130 |
Why?
|
| Radiotherapy | 4 | 2013 | 1497 | 0.130 |
Why?
|
| Carcinoma, Adenosquamous | 1 | 2015 | 65 | 0.130 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 5 | 2009 | 138 | 0.130 |
Why?
|
| Tumor Burden | 4 | 2016 | 1892 | 0.120 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2012 | 487 | 0.120 |
Why?
|
| Specialization | 2 | 2017 | 778 | 0.120 |
Why?
|
| Anti-Bacterial Agents | 5 | 2021 | 7403 | 0.120 |
Why?
|
| Travel | 1 | 2021 | 796 | 0.120 |
Why?
|
| Nova Scotia | 1 | 2014 | 34 | 0.120 |
Why?
|
| Cholangiography | 12 | 2004 | 181 | 0.120 |
Why?
|
| Malpractice | 2 | 2006 | 556 | 0.120 |
Why?
|
| Gastric Emptying | 5 | 2013 | 243 | 0.120 |
Why?
|
| Enteroendocrine Cells | 1 | 2016 | 78 | 0.120 |
Why?
|
| Ethics, Professional | 10 | 2002 | 100 | 0.120 |
Why?
|
| Wound Healing | 6 | 2015 | 2802 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2003 | 1204 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2006 | 1276 | 0.120 |
Why?
|
| Phosphates | 1 | 2018 | 769 | 0.120 |
Why?
|
| Diverticulitis, Colonic | 3 | 1998 | 138 | 0.120 |
Why?
|
| Peritoneal Cavity | 2 | 1995 | 135 | 0.120 |
Why?
|
| Point Mutation | 2 | 2015 | 1595 | 0.120 |
Why?
|
| Surgical Wound Infection | 3 | 2019 | 1529 | 0.120 |
Why?
|
| Gastroenterostomy | 1 | 2014 | 18 | 0.120 |
Why?
|
| New York | 3 | 2021 | 875 | 0.120 |
Why?
|
| Creatinine | 11 | 1979 | 1895 | 0.120 |
Why?
|
| Incidental Findings | 4 | 2015 | 697 | 0.120 |
Why?
|
| Academic Medical Centers | 5 | 2017 | 2756 | 0.120 |
Why?
|
| Proportional Hazards Models | 10 | 2020 | 12448 | 0.120 |
Why?
|
| Paraffin Embedding | 1 | 2015 | 302 | 0.120 |
Why?
|
| Tissue Fixation | 1 | 2015 | 241 | 0.120 |
Why?
|
| Beer | 1 | 1994 | 134 | 0.120 |
Why?
|
| Unnecessary Procedures | 1 | 2018 | 414 | 0.120 |
Why?
|
| Hospital Mortality | 6 | 2019 | 5292 | 0.120 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2015 | 592 | 0.120 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2017 | 926 | 0.120 |
Why?
|
| Bile Duct Diseases | 1 | 2014 | 97 | 0.110 |
Why?
|
| Insulinoma | 4 | 2008 | 121 | 0.110 |
Why?
|
| Clinical Competence | 4 | 2017 | 4790 | 0.110 |
Why?
|
| Physiology | 1 | 2014 | 111 | 0.110 |
Why?
|
| DNA, Neoplasm | 3 | 1997 | 1743 | 0.110 |
Why?
|
| Prevalence | 5 | 2020 | 15702 | 0.110 |
Why?
|
| Carcinoma in Situ | 5 | 2013 | 791 | 0.110 |
Why?
|
| Cost Control | 2 | 2012 | 627 | 0.110 |
Why?
|
| Gallstones | 8 | 2011 | 284 | 0.110 |
Why?
|
| Metaplasia | 5 | 2016 | 324 | 0.110 |
Why?
|
| Ciprofloxacin | 1 | 1996 | 312 | 0.110 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2002 | 2008 | 0.110 |
Why?
|
| Dexamethasone | 2 | 2018 | 1946 | 0.110 |
Why?
|
| Random Allocation | 11 | 2001 | 2392 | 0.110 |
Why?
|
| Isoamylase | 6 | 1995 | 10 | 0.110 |
Why?
|
| Health Policy | 3 | 2017 | 2682 | 0.110 |
Why?
|
| Enzyme Activation | 8 | 1999 | 3591 | 0.110 |
Why?
|
| Pain | 9 | 1996 | 5062 | 0.110 |
Why?
|
| Cell Line, Tumor | 9 | 2020 | 16968 | 0.110 |
Why?
|
| Splenic Artery | 3 | 2009 | 57 | 0.110 |
Why?
|
| Organoplatinum Compounds | 1 | 2015 | 407 | 0.110 |
Why?
|
| Hypocalcemia | 4 | 1990 | 200 | 0.110 |
Why?
|
| Cholestasis, Extrahepatic | 4 | 1984 | 52 | 0.110 |
Why?
|
| Germany | 2 | 2020 | 872 | 0.100 |
Why?
|
| Methods | 10 | 1988 | 1065 | 0.100 |
Why?
|
| Duodenal Obstruction | 2 | 1990 | 23 | 0.100 |
Why?
|
| Thiophenes | 3 | 2002 | 569 | 0.100 |
Why?
|
| Cellulitis | 2 | 1990 | 209 | 0.100 |
Why?
|
| Cholangiocarcinoma | 2 | 2017 | 553 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 3 | 2020 | 2644 | 0.100 |
Why?
|
| Cholecystitis | 2 | 1993 | 180 | 0.100 |
Why?
|
| Constriction, Pathologic | 6 | 1996 | 1096 | 0.100 |
Why?
|
| Congresses as Topic | 2 | 2015 | 802 | 0.100 |
Why?
|
| Young Adult | 16 | 2020 | 59191 | 0.100 |
Why?
|
| Music | 2 | 2012 | 245 | 0.100 |
Why?
|
| Pancreatic Juice | 6 | 2002 | 60 | 0.100 |
Why?
|
| Gastroparesis | 1 | 2014 | 138 | 0.100 |
Why?
|
| Friends | 1 | 2013 | 148 | 0.100 |
Why?
|
| Violence | 1 | 2018 | 936 | 0.100 |
Why?
|
| Negotiating | 1 | 1993 | 150 | 0.100 |
Why?
|
| Phenylephrine | 2 | 1994 | 293 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 1 | 2020 | 1350 | 0.100 |
Why?
|
| Epithelium | 1 | 2016 | 1603 | 0.100 |
Why?
|
| Gallbladder Neoplasms | 2 | 2011 | 189 | 0.100 |
Why?
|
| Truth Disclosure | 1 | 2015 | 432 | 0.090 |
Why?
|
| Antigens, Neoplasm | 3 | 2012 | 1985 | 0.090 |
Why?
|
| Liability, Legal | 1 | 2012 | 210 | 0.090 |
Why?
|
| Camptothecin | 1 | 2015 | 591 | 0.090 |
Why?
|
| Adolescent | 30 | 2020 | 88247 | 0.090 |
Why?
|
| Embolism, Cholesterol | 1 | 2010 | 32 | 0.090 |
Why?
|
| Research Support as Topic | 10 | 2002 | 697 | 0.090 |
Why?
|
| Interprofessional Relations | 3 | 2009 | 991 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2005 | 5074 | 0.090 |
Why?
|
| Models, Animal | 3 | 2014 | 2108 | 0.090 |
Why?
|
| Quality Assurance, Health Care | 2 | 2014 | 2164 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2001 | 2909 | 0.090 |
Why?
|
| Survivors | 2 | 2021 | 2373 | 0.090 |
Why?
|
| Specialties, Surgical | 2 | 2010 | 390 | 0.090 |
Why?
|
| Common Bile Duct | 7 | 1985 | 106 | 0.090 |
Why?
|
| Communication | 2 | 2009 | 3851 | 0.090 |
Why?
|
| Perineum | 2 | 1985 | 208 | 0.090 |
Why?
|
| Glucose | 1 | 2002 | 4345 | 0.090 |
Why?
|
| Insurance, Liability | 2 | 2006 | 101 | 0.090 |
Why?
|
| Radiography | 15 | 1993 | 6961 | 0.090 |
Why?
|
| Urinary Catheterization | 1 | 1991 | 193 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 9 | 2004 | 1738 | 0.090 |
Why?
|
| Cause of Death | 2 | 2020 | 3683 | 0.090 |
Why?
|
| Proteins | 7 | 1998 | 6030 | 0.090 |
Why?
|
| Disaster Planning | 1 | 2016 | 557 | 0.090 |
Why?
|
| Polyps | 1 | 2011 | 200 | 0.090 |
Why?
|
| Severity of Illness Index | 9 | 2011 | 15829 | 0.080 |
Why?
|
| Injections, Intravenous | 4 | 2001 | 1376 | 0.080 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 1990 | 92 | 0.080 |
Why?
|
| Hypotension | 3 | 1995 | 879 | 0.080 |
Why?
|
| Clinical Enzyme Tests | 4 | 1984 | 113 | 0.080 |
Why?
|
| Urine | 1 | 1991 | 362 | 0.080 |
Why?
|
| Colitis | 1 | 1998 | 1234 | 0.080 |
Why?
|
| Intestinal Absorption | 4 | 1977 | 400 | 0.080 |
Why?
|
| Combined Modality Therapy | 11 | 2022 | 8516 | 0.080 |
Why?
|
| ras Proteins | 1 | 2015 | 1054 | 0.080 |
Why?
|
| Energy Metabolism | 2 | 2012 | 2878 | 0.080 |
Why?
|
| Mutation | 11 | 2016 | 30015 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 1996 | 1023 | 0.080 |
Why?
|
| Skin Diseases | 3 | 1989 | 1094 | 0.080 |
Why?
|
| Immunohistochemistry | 9 | 2019 | 11069 | 0.080 |
Why?
|
| Obesity | 1 | 2011 | 12934 | 0.080 |
Why?
|
| Forecasting | 2 | 2017 | 2924 | 0.080 |
Why?
|
| Suture Techniques | 3 | 2010 | 768 | 0.080 |
Why?
|
| Watchful Waiting | 1 | 2013 | 491 | 0.080 |
Why?
|
| Mice, Nude | 6 | 2020 | 3606 | 0.080 |
Why?
|
| Mice | 18 | 2020 | 81368 | 0.080 |
Why?
|
| Biliary Fistula | 3 | 1986 | 37 | 0.080 |
Why?
|
| Educational Measurement | 2 | 2006 | 1252 | 0.080 |
Why?
|
| Glucocorticoids | 1 | 2018 | 2160 | 0.080 |
Why?
|
| Doxycycline | 1 | 2011 | 344 | 0.080 |
Why?
|
| Radiotherapy Dosage | 5 | 2012 | 2897 | 0.080 |
Why?
|
| Magnetic Resonance Angiography | 1 | 1996 | 1431 | 0.080 |
Why?
|
| Cell Differentiation | 5 | 2016 | 11512 | 0.080 |
Why?
|
| Anniversaries and Special Events | 1 | 2009 | 95 | 0.080 |
Why?
|
| Thienamycins | 2 | 2000 | 29 | 0.080 |
Why?
|
| Embolism, Air | 1 | 2009 | 109 | 0.080 |
Why?
|
| Drug Industry | 10 | 2002 | 788 | 0.080 |
Why?
|
| Magnesium Deficiency | 1 | 1989 | 48 | 0.080 |
Why?
|
| Catheterization | 7 | 1992 | 1428 | 0.080 |
Why?
|
| Hemoglobins | 6 | 1996 | 1524 | 0.080 |
Why?
|
| Hyperlipidemias | 4 | 1979 | 770 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 4172 | 0.080 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2012 | 1784 | 0.080 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2012 | 702 | 0.080 |
Why?
|
| Risk Assessment | 6 | 2021 | 23974 | 0.080 |
Why?
|
| Mental Processes | 1 | 2009 | 243 | 0.080 |
Why?
|
| Postoperative Care | 3 | 2023 | 1467 | 0.080 |
Why?
|
| Cohort Studies | 14 | 2020 | 41464 | 0.080 |
Why?
|
| Costs and Cost Analysis | 3 | 2006 | 1663 | 0.080 |
Why?
|
| Interdisciplinary Communication | 2 | 2011 | 928 | 0.080 |
Why?
|
| Peritoneal Lavage | 4 | 2000 | 30 | 0.080 |
Why?
|
| Liver Diseases | 2 | 1993 | 1297 | 0.080 |
Why?
|
| Risk Factors | 17 | 2023 | 74128 | 0.080 |
Why?
|
| Anastomosis, Surgical | 4 | 2010 | 982 | 0.080 |
Why?
|
| Fatty Acids, Nonesterified | 2 | 1990 | 393 | 0.080 |
Why?
|
| Ascites | 4 | 1994 | 338 | 0.080 |
Why?
|
| Lymphoma | 1 | 2017 | 1899 | 0.070 |
Why?
|
| Peripheral Nerves | 1 | 2011 | 479 | 0.070 |
Why?
|
| Chi-Square Distribution | 6 | 2009 | 3410 | 0.070 |
Why?
|
| Tuberculosis | 1 | 2001 | 2015 | 0.070 |
Why?
|
| Multivariate Analysis | 7 | 2020 | 12043 | 0.070 |
Why?
|
| Surgical Stapling | 1 | 2008 | 98 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2011 | 2048 | 0.070 |
Why?
|
| Postoperative Period | 4 | 2020 | 1812 | 0.070 |
Why?
|
| Insurance, Health | 2 | 2021 | 2495 | 0.070 |
Why?
|
| Pyloric Antrum | 3 | 2000 | 66 | 0.070 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 1988 | 67 | 0.070 |
Why?
|
| Mesentery | 3 | 2005 | 202 | 0.070 |
Why?
|
| Mentors | 1 | 2013 | 661 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 6520 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 8542 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 1901 | 0.070 |
Why?
|
| Catheterization, Peripheral | 1 | 2011 | 343 | 0.070 |
Why?
|
| Neoplasm Transplantation | 3 | 2020 | 2010 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 1890 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2010 | 1056 | 0.070 |
Why?
|
| Burnout, Professional | 2 | 2006 | 703 | 0.070 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 1993 | 1116 | 0.070 |
Why?
|
| Body Fluids | 4 | 2004 | 320 | 0.070 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 1980 | 296 | 0.070 |
Why?
|
| Malabsorption Syndromes | 3 | 1973 | 135 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 1790 | 0.070 |
Why?
|
| Reoperation | 5 | 2021 | 4300 | 0.070 |
Why?
|
| Cell Line | 3 | 2022 | 15577 | 0.070 |
Why?
|
| Sensitivity and Specificity | 10 | 2020 | 14649 | 0.070 |
Why?
|
| Coloring Agents | 2 | 2016 | 562 | 0.070 |
Why?
|
| Intestinal Mucosa | 6 | 1997 | 3031 | 0.070 |
Why?
|
| Motor Skills | 1 | 2009 | 521 | 0.070 |
Why?
|
| Receptors, Estrogen | 1 | 1995 | 2208 | 0.070 |
Why?
|
| Specimen Handling | 1 | 1991 | 701 | 0.070 |
Why?
|
| Venous Thromboembolism | 1 | 2019 | 1866 | 0.070 |
Why?
|
| Calcium Chloride | 3 | 1995 | 78 | 0.070 |
Why?
|
| Neoplasm Metastasis | 7 | 2020 | 4910 | 0.070 |
Why?
|
| Social Environment | 1 | 2011 | 1021 | 0.070 |
Why?
|
| ROC Curve | 4 | 2019 | 3575 | 0.070 |
Why?
|
| Protein C | 1 | 2006 | 133 | 0.070 |
Why?
|
| Pulmonary Edema | 3 | 2001 | 407 | 0.060 |
Why?
|
| Stress, Physiological | 2 | 2012 | 1403 | 0.060 |
Why?
|
| Peptic Ulcer | 3 | 1996 | 217 | 0.060 |
Why?
|
| Histones | 1 | 2016 | 2577 | 0.060 |
Why?
|
| Robotics | 1 | 2012 | 817 | 0.060 |
Why?
|
| Colectomy | 5 | 2006 | 686 | 0.060 |
Why?
|
| Platelet Count | 1 | 2008 | 780 | 0.060 |
Why?
|
| Safety Management | 1 | 2011 | 760 | 0.060 |
Why?
|
| Evans Blue | 2 | 2002 | 42 | 0.060 |
Why?
|
| Sphincter of Oddi | 1 | 1985 | 21 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2015 | 36401 | 0.060 |
Why?
|
| Pituitary-Adrenal System | 1 | 2008 | 553 | 0.060 |
Why?
|
| Japan | 1 | 2009 | 1372 | 0.060 |
Why?
|
| Lymphatic System | 3 | 1978 | 253 | 0.060 |
Why?
|
| California | 2 | 2021 | 1431 | 0.060 |
Why?
|
| Keratins | 2 | 2004 | 498 | 0.060 |
Why?
|
| Paintings | 1 | 2006 | 103 | 0.060 |
Why?
|
| Cross-Over Studies | 3 | 2012 | 2079 | 0.060 |
Why?
|
| Pancreatic Elastase | 1 | 2005 | 127 | 0.060 |
Why?
|
| Auditory Perception | 1 | 2009 | 583 | 0.060 |
Why?
|
| Viscosity | 3 | 1995 | 336 | 0.060 |
Why?
|
| Hospitals, Veterans | 1 | 2007 | 395 | 0.060 |
Why?
|
| Hypertension, Portal | 1 | 1987 | 227 | 0.060 |
Why?
|
| Starch | 3 | 1974 | 79 | 0.060 |
Why?
|
| Biopsy | 4 | 2014 | 6763 | 0.060 |
Why?
|
| Job Satisfaction | 2 | 2006 | 544 | 0.060 |
Why?
|
| S100 Proteins | 1 | 2005 | 217 | 0.060 |
Why?
|
| Family | 2 | 2013 | 3193 | 0.060 |
Why?
|
| Colonic Neoplasms | 5 | 2010 | 2533 | 0.060 |
Why?
|
| Uterine Diseases | 1 | 1985 | 108 | 0.060 |
Why?
|
| International Cooperation | 1 | 2011 | 1422 | 0.060 |
Why?
|
| Referral and Consultation | 1 | 2017 | 3599 | 0.060 |
Why?
|
| Splenic Diseases | 2 | 2017 | 90 | 0.060 |
Why?
|
| Carcinoma, Ductal | 1 | 2004 | 97 | 0.060 |
Why?
|
| Lung Neoplasms | 5 | 2018 | 13383 | 0.060 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 15250 | 0.060 |
Why?
|
| Insurance Coverage | 1 | 2015 | 1937 | 0.060 |
Why?
|
| Cardiopulmonary Bypass | 5 | 2005 | 1092 | 0.060 |
Why?
|
| Ki-67 Antigen | 2 | 2016 | 627 | 0.060 |
Why?
|
| Signal Transduction | 4 | 2020 | 23415 | 0.060 |
Why?
|
| Rectum | 2 | 1985 | 891 | 0.060 |
Why?
|
| Decision Trees | 1 | 2005 | 504 | 0.060 |
Why?
|
| Macrophages | 1 | 2019 | 5758 | 0.060 |
Why?
|
| Hyperplasia | 3 | 2023 | 1150 | 0.060 |
Why?
|
| Leucine | 3 | 1998 | 548 | 0.060 |
Why?
|
| Boston | 5 | 2017 | 9313 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2005 | 550 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2005 | 328 | 0.050 |
Why?
|
| Oxygen | 1 | 1995 | 4226 | 0.050 |
Why?
|
| Esophagitis, Peptic | 1 | 1984 | 76 | 0.050 |
Why?
|
| Capillary Permeability | 3 | 2002 | 773 | 0.050 |
Why?
|
| Stomach Diseases | 1 | 1984 | 134 | 0.050 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2007 | 339 | 0.050 |
Why?
|
| Colitis, Ulcerative | 4 | 1985 | 1921 | 0.050 |
Why?
|
| Dietary Proteins | 2 | 2001 | 951 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 1995 | 5109 | 0.050 |
Why?
|
| Autoimmune Diseases | 2 | 2005 | 2238 | 0.050 |
Why?
|
| Patient Protection and Affordable Care Act | 1 | 2012 | 1187 | 0.050 |
Why?
|
| Gastrointestinal Agents | 2 | 1998 | 510 | 0.050 |
Why?
|
| Calcitonin | 2 | 1982 | 329 | 0.050 |
Why?
|
| Health Care Surveys | 2 | 2011 | 2422 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 1999 | 9171 | 0.050 |
Why?
|
| Edetic Acid | 2 | 2002 | 276 | 0.050 |
Why?
|
| Indomethacin | 2 | 1981 | 323 | 0.050 |
Why?
|
| Endoscopes | 2 | 1981 | 168 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2015 | 4512 | 0.050 |
Why?
|
| Choline Deficiency | 2 | 1994 | 23 | 0.050 |
Why?
|
| Morbidity | 3 | 2007 | 1750 | 0.050 |
Why?
|
| Socioeconomic Factors | 4 | 2017 | 7805 | 0.050 |
Why?
|
| Stem Cells | 1 | 2015 | 3514 | 0.050 |
Why?
|
| Adult Children | 1 | 2022 | 103 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2020 | 3599 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2005 | 4340 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 3492 | 0.050 |
Why?
|
| Nutritional Support | 1 | 2003 | 173 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2005 | 624 | 0.050 |
Why?
|
| Pyridoxal Phosphate | 1 | 2002 | 121 | 0.050 |
Why?
|
| Ligaments | 1 | 1982 | 127 | 0.050 |
Why?
|
| Complement Inactivator Proteins | 1 | 2001 | 74 | 0.050 |
Why?
|
| Cytodiagnosis | 2 | 1998 | 447 | 0.050 |
Why?
|
| Social Change | 1 | 2002 | 153 | 0.050 |
Why?
|
| Cell Proliferation | 4 | 2020 | 10429 | 0.050 |
Why?
|
| Cell Lineage | 2 | 2007 | 2553 | 0.050 |
Why?
|
| Pennsylvania | 1 | 2003 | 612 | 0.050 |
Why?
|
| Linear Models | 2 | 2006 | 5866 | 0.050 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2001 | 114 | 0.050 |
Why?
|
| Professional Practice | 1 | 2003 | 313 | 0.050 |
Why?
|
| Inpatients | 2 | 2011 | 2545 | 0.050 |
Why?
|
| Cystadenoma, Papillary | 1 | 2001 | 9 | 0.050 |
Why?
|
| Sympathetic Nervous System | 2 | 2012 | 519 | 0.050 |
Why?
|
| Cilastatin | 1 | 2000 | 12 | 0.050 |
Why?
|
| Ileum | 3 | 1984 | 557 | 0.050 |
Why?
|
| Direct Service Costs | 1 | 2001 | 59 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 5789 | 0.050 |
Why?
|
| Governing Board | 1 | 2001 | 50 | 0.050 |
Why?
|
| Cells, Cultured | 5 | 2009 | 18937 | 0.050 |
Why?
|
| Antacids | 2 | 2017 | 94 | 0.050 |
Why?
|
| Hemodynamics | 5 | 1998 | 4160 | 0.050 |
Why?
|
| Tissue Adhesives | 1 | 2002 | 173 | 0.050 |
Why?
|
| Dogs | 4 | 2002 | 3837 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2002 | 349 | 0.050 |
Why?
|
| Treatment Failure | 3 | 1998 | 2635 | 0.050 |
Why?
|
| Frozen Sections | 1 | 2021 | 153 | 0.050 |
Why?
|
| Stress, Psychological | 2 | 2013 | 4488 | 0.040 |
Why?
|
| Guanidines | 1 | 2001 | 194 | 0.040 |
Why?
|
| Salivary Gland Diseases | 2 | 1977 | 37 | 0.040 |
Why?
|
| Peritonitis | 2 | 1973 | 368 | 0.040 |
Why?
|
| Qualitative Research | 2 | 2021 | 3017 | 0.040 |
Why?
|
| Jaundice | 2 | 2015 | 94 | 0.040 |
Why?
|
| Glycoside Hydrolases | 1 | 1980 | 135 | 0.040 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2005 | 1118 | 0.040 |
Why?
|
| Mixed Function Oxygenases | 1 | 2001 | 265 | 0.040 |
Why?
|
| Genes, MHC Class I | 1 | 2021 | 235 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2018 | 2916 | 0.040 |
Why?
|
| Patient Care Planning | 1 | 1986 | 905 | 0.040 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2008 | 955 | 0.040 |
Why?
|
| Endopeptidases | 2 | 2001 | 774 | 0.040 |
Why?
|
| Algorithms | 5 | 2009 | 14024 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2004 | 3798 | 0.040 |
Why?
|
| Intestines | 4 | 2005 | 1909 | 0.040 |
Why?
|
| Technetium Compounds | 1 | 1999 | 15 | 0.040 |
Why?
|
| Microscopy, Electron | 3 | 2002 | 2561 | 0.040 |
Why?
|
| Serum Albumin, Bovine | 3 | 1977 | 321 | 0.040 |
Why?
|
| Nicotinic Acids | 1 | 1999 | 31 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 1989 | 2188 | 0.040 |
Why?
|
| Liver | 5 | 2011 | 7512 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2002 | 459 | 0.040 |
Why?
|
| Insulin-Secreting Cells | 1 | 2007 | 898 | 0.040 |
Why?
|
| Meglumine | 1 | 2000 | 143 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2022 | 550 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2002 | 755 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 1982 | 420 | 0.040 |
Why?
|
| Abdominal Neoplasms | 1 | 1981 | 287 | 0.040 |
Why?
|
| Disease Progression | 5 | 2020 | 13495 | 0.040 |
Why?
|
| Efficiency | 1 | 2022 | 476 | 0.040 |
Why?
|
| Blood Loss, Surgical | 1 | 2023 | 636 | 0.040 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2001 | 412 | 0.040 |
Why?
|
| Troponin I | 1 | 2003 | 650 | 0.040 |
Why?
|
| ABO Blood-Group System | 1 | 2021 | 380 | 0.040 |
Why?
|
| Gloves, Surgical | 3 | 1974 | 24 | 0.040 |
Why?
|
| Rabbits | 3 | 1995 | 4770 | 0.040 |
Why?
|
| Rats, Inbred Lew | 1 | 2001 | 1157 | 0.040 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2000 | 189 | 0.040 |
Why?
|
| Patient Readmission | 1 | 2013 | 3269 | 0.040 |
Why?
|
| Critical Illness | 2 | 2009 | 2709 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 2001 | 426 | 0.040 |
Why?
|
| Analysis of Variance | 3 | 2009 | 6223 | 0.040 |
Why?
|
| Sodium Chloride | 3 | 1994 | 586 | 0.040 |
Why?
|
| Endoscopy | 5 | 1996 | 1851 | 0.040 |
Why?
|
| Syndrome | 3 | 1993 | 3268 | 0.040 |
Why?
|
| Complement Activation | 1 | 2001 | 445 | 0.040 |
Why?
|
| Stents | 1 | 2011 | 3177 | 0.040 |
Why?
|
| Kidney Neoplasms | 2 | 2010 | 4252 | 0.040 |
Why?
|
| Gabexate | 2 | 2001 | 12 | 0.040 |
Why?
|
| Pancreatic Function Tests | 2 | 1990 | 69 | 0.040 |
Why?
|
| Carcinogens | 2 | 1999 | 452 | 0.040 |
Why?
|
| Hospitals, Teaching | 1 | 2003 | 1155 | 0.040 |
Why?
|
| Aneurysm | 2 | 1991 | 337 | 0.040 |
Why?
|
| Biliary Tract | 1 | 2019 | 135 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2000 | 451 | 0.040 |
Why?
|
| Cholangitis | 3 | 1976 | 111 | 0.040 |
Why?
|
| Risk | 3 | 2006 | 9603 | 0.040 |
Why?
|
| Child | 12 | 2011 | 80089 | 0.040 |
Why?
|
| Blotting, Western | 4 | 2009 | 5034 | 0.040 |
Why?
|
| Nitroprusside | 1 | 1998 | 272 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2000 | 393 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 1999 | 696 | 0.040 |
Why?
|
| Bacteria | 3 | 2008 | 2192 | 0.040 |
Why?
|
| Anxiety | 1 | 2013 | 4573 | 0.040 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1998 | 260 | 0.040 |
Why?
|
| APACHE | 1 | 1998 | 267 | 0.040 |
Why?
|
| Italy | 1 | 2020 | 842 | 0.040 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 2 | 2011 | 100 | 0.040 |
Why?
|
| Multiple Organ Failure | 1 | 2000 | 387 | 0.040 |
Why?
|
| Colon | 4 | 1985 | 1791 | 0.040 |
Why?
|
| Escherichia coli Infections | 2 | 1994 | 518 | 0.040 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1248 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 3 | 1998 | 2803 | 0.040 |
Why?
|
| Cathepsin B | 1 | 1998 | 80 | 0.040 |
Why?
|
| Oxyhemoglobins | 2 | 1996 | 212 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11874 | 0.040 |
Why?
|
| Veratrum Alkaloids | 2 | 2010 | 23 | 0.040 |
Why?
|
| Secretin | 2 | 1990 | 57 | 0.040 |
Why?
|
| Incidence | 5 | 2017 | 21339 | 0.040 |
Why?
|
| Genes, Retinoblastoma | 1 | 1997 | 125 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5334 | 0.040 |
Why?
|
| Intestinal Perforation | 2 | 1977 | 249 | 0.040 |
Why?
|
| Cell Fractionation | 1 | 1998 | 249 | 0.040 |
Why?
|
| Denervation | 1 | 1998 | 265 | 0.040 |
Why?
|
| Gastrostomy | 2 | 1985 | 323 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2001 | 1635 | 0.040 |
Why?
|
| Diabetic Ketoacidosis | 2 | 1978 | 253 | 0.040 |
Why?
|
| Regeneration | 3 | 2015 | 1505 | 0.040 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2017 | 80 | 0.040 |
Why?
|
| Carbachol | 1 | 1997 | 223 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 9417 | 0.040 |
Why?
|
| Kidney | 4 | 1976 | 7044 | 0.040 |
Why?
|
| Genes, p53 | 1 | 1999 | 712 | 0.040 |
Why?
|
| Lipase | 4 | 1995 | 324 | 0.040 |
Why?
|
| Abdominal Abscess | 1 | 2018 | 153 | 0.040 |
Why?
|
| Biliary Tract Neoplasms | 3 | 1993 | 185 | 0.030 |
Why?
|
| Mucin-6 | 1 | 2016 | 15 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 1998 | 531 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2012 | 3801 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1997 | 531 | 0.030 |
Why?
|
| Abdominal Pain | 2 | 2015 | 1070 | 0.030 |
Why?
|
| Heparin | 2 | 2019 | 1632 | 0.030 |
Why?
|
| Kidney Diseases | 2 | 1995 | 2090 | 0.030 |
Why?
|
| Genital Diseases, Male | 1 | 1977 | 83 | 0.030 |
Why?
|
| Calcinosis | 3 | 2012 | 1469 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2005 | 1202 | 0.030 |
Why?
|
| Epidermal Cyst | 1 | 2017 | 64 | 0.030 |
Why?
|
| Immunotherapy | 1 | 2012 | 4642 | 0.030 |
Why?
|
| Hospitals, Community | 1 | 1999 | 365 | 0.030 |
Why?
|
| Sepsis | 3 | 2019 | 2585 | 0.030 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 1990 | 86 | 0.030 |
Why?
|
| Hematoxylin | 1 | 2016 | 60 | 0.030 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2016 | 69 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2019 | 8311 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2000 | 646 | 0.030 |
Why?
|
| Hospital Charges | 1 | 1998 | 350 | 0.030 |
Why?
|
| Mucin 5AC | 1 | 2016 | 96 | 0.030 |
Why?
|
| Telomerase | 1 | 2001 | 744 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2270 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1997 | 322 | 0.030 |
Why?
|
| Protein-Losing Enteropathies | 2 | 1973 | 45 | 0.030 |
Why?
|
| Carcinoma, Islet Cell | 1 | 1995 | 21 | 0.030 |
Why?
|
| Endothelium, Vascular | 2 | 2005 | 4433 | 0.030 |
Why?
|
| Ligases | 1 | 1997 | 333 | 0.030 |
Why?
|
| Shock | 1 | 1978 | 314 | 0.030 |
Why?
|
| Gene Deletion | 3 | 1998 | 2659 | 0.030 |
Why?
|
| Career Choice | 1 | 2002 | 757 | 0.030 |
Why?
|
| Cefotaxime | 1 | 1995 | 35 | 0.030 |
Why?
|
| Genome, Human | 1 | 2009 | 4421 | 0.030 |
Why?
|
| Abdomen | 2 | 1979 | 1128 | 0.030 |
Why?
|
| Genital Diseases, Female | 1 | 1977 | 192 | 0.030 |
Why?
|
| Collagen | 2 | 2020 | 2634 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 1996 | 309 | 0.030 |
Why?
|
| Cecal Diseases | 1 | 1995 | 49 | 0.030 |
Why?
|
| Liver Transplantation | 2 | 2001 | 2328 | 0.030 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 3 | 2001 | 58 | 0.030 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2010 | 3164 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1998 | 908 | 0.030 |
Why?
|
| Sodium Hydroxide | 2 | 1988 | 37 | 0.030 |
Why?
|
| Tobramycin | 1 | 1995 | 65 | 0.030 |
Why?
|
| Fever | 2 | 1981 | 1618 | 0.030 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 1976 | 108 | 0.030 |
Why?
|
| Smad4 Protein | 1 | 2016 | 191 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2021 | 1329 | 0.030 |
Why?
|
| Colistin | 1 | 1995 | 44 | 0.030 |
Why?
|
| Amphotericin B | 1 | 1995 | 142 | 0.030 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 1995 | 98 | 0.030 |
Why?
|
| Capillaries | 2 | 1996 | 756 | 0.030 |
Why?
|
| Case-Control Studies | 4 | 2017 | 22153 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 1999 | 876 | 0.030 |
Why?
|
| Body Weight | 2 | 1984 | 4615 | 0.030 |
Why?
|
| Genes, myc | 1 | 2016 | 390 | 0.030 |
Why?
|
| SEER Program | 1 | 2020 | 1450 | 0.030 |
Why?
|
| Pneumonia | 3 | 2018 | 2143 | 0.030 |
Why?
|
| Ethionine | 1 | 1994 | 10 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 994 | 0.030 |
Why?
|
| Databases, Factual | 2 | 2020 | 7963 | 0.030 |
Why?
|
| Enzyme Precursors | 1 | 1995 | 170 | 0.030 |
Why?
|
| Pentoxifylline | 1 | 1994 | 53 | 0.030 |
Why?
|
| Arginine | 1 | 1998 | 933 | 0.030 |
Why?
|
| Gastroesophageal Reflux | 1 | 1982 | 821 | 0.030 |
Why?
|
| Exudates and Transudates | 1 | 1995 | 174 | 0.030 |
Why?
|
| Economics, Medical | 1 | 1995 | 112 | 0.030 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 1995 | 119 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 3 | 2001 | 6074 | 0.030 |
Why?
|
| Office Visits | 1 | 1999 | 593 | 0.030 |
Why?
|
| Spiral Cone-Beam Computed Tomography | 1 | 2015 | 34 | 0.030 |
Why?
|
| Gadolinium DTPA | 1 | 1998 | 823 | 0.030 |
Why?
|
| Filtration | 1 | 2015 | 228 | 0.030 |
Why?
|
| Critical Care | 3 | 2013 | 2691 | 0.030 |
Why?
|
| False Negative Reactions | 2 | 1986 | 573 | 0.030 |
Why?
|
| Endothelial Cells | 2 | 2004 | 3550 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 1997 | 642 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 1998 | 973 | 0.030 |
Why?
|
| Scattering, Radiation | 1 | 1996 | 490 | 0.030 |
Why?
|
| Medicare | 3 | 2021 | 6774 | 0.030 |
Why?
|
| Prednisone | 2 | 1976 | 1562 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 1994 | 328 | 0.030 |
Why?
|
| Pleurisy | 1 | 1974 | 54 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 451 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2003 | 2851 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2017 | 2382 | 0.030 |
Why?
|
| Glutamine | 1 | 1997 | 576 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 3776 | 0.030 |
Why?
|
| Pneumonectomy | 2 | 2006 | 1119 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 5 | 1997 | 1624 | 0.030 |
Why?
|
| Ileus | 1 | 2013 | 66 | 0.030 |
Why?
|
| Patient Selection | 2 | 2015 | 4237 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 7873 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2019 | 1327 | 0.030 |
Why?
|
| Infusions, Intravenous | 3 | 1994 | 2214 | 0.030 |
Why?
|
| Ligation | 1 | 1994 | 446 | 0.030 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 2419 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2001 | 1995 | 0.030 |
Why?
|
| Enterococcus | 1 | 1994 | 159 | 0.030 |
Why?
|
| Saliva | 3 | 1988 | 828 | 0.030 |
Why?
|
| Cell Communication | 1 | 2020 | 1654 | 0.030 |
Why?
|
| Streptokinase | 1 | 1993 | 186 | 0.030 |
Why?
|
| DNA Primers | 1 | 1997 | 2817 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1998 | 4611 | 0.030 |
Why?
|
| Superinfection | 1 | 1993 | 63 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 1088 | 0.030 |
Why?
|
| Cattle | 2 | 1995 | 3841 | 0.030 |
Why?
|
| Failure to Thrive | 1 | 2013 | 140 | 0.030 |
Why?
|
| Isotonic Solutions | 1 | 1993 | 117 | 0.030 |
Why?
|
| Propensity Score | 1 | 2020 | 1912 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 836 | 0.030 |
Why?
|
| Sex Factors | 2 | 2012 | 10549 | 0.030 |
Why?
|
| Anticoagulants | 2 | 2019 | 4785 | 0.030 |
Why?
|
| Saline Solution, Hypertonic | 1 | 1993 | 114 | 0.030 |
Why?
|
| Peptide Biosynthesis | 1 | 1992 | 52 | 0.030 |
Why?
|
| Pancytopenia | 1 | 1993 | 102 | 0.030 |
Why?
|
| Cholecystolithiasis | 1 | 2011 | 7 | 0.030 |
Why?
|
| Cytoplasmic Granules | 1 | 1995 | 573 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 1226 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2018 | 802 | 0.020 |
Why?
|
| Smoking | 2 | 2023 | 9054 | 0.020 |
Why?
|
| Imidazoles | 1 | 1998 | 1175 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2002 | 3705 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2001 | 4117 | 0.020 |
Why?
|
| Public Policy | 1 | 2016 | 557 | 0.020 |
Why?
|
| DNA Mutational Analysis | 2 | 2016 | 4110 | 0.020 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 1994 | 342 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4569 | 0.020 |
Why?
|
| Leadership | 1 | 2001 | 1385 | 0.020 |
Why?
|
| Peroxidases | 1 | 1971 | 134 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2017 | 705 | 0.020 |
Why?
|
| Regional Blood Flow | 2 | 1993 | 1496 | 0.020 |
Why?
|
| Iliac Artery | 1 | 1973 | 343 | 0.020 |
Why?
|
| Hepatic Duct, Common | 3 | 1988 | 48 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 7390 | 0.020 |
Why?
|
| Patient Admission | 1 | 1999 | 1365 | 0.020 |
Why?
|
| Appendicitis | 1 | 1998 | 675 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2015 | 1525 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2012 | 20077 | 0.020 |
Why?
|
| Fat Necrosis | 1 | 1991 | 60 | 0.020 |
Why?
|
| Kidney Function Tests | 3 | 1979 | 677 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2015 | 1575 | 0.020 |
Why?
|
| Antigens, Bacterial | 1 | 1977 | 1141 | 0.020 |
Why?
|
| Cholestasis, Intrahepatic | 2 | 1982 | 75 | 0.020 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 865 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2015 | 8619 | 0.020 |
Why?
|
| Perfusion | 1 | 1996 | 1373 | 0.020 |
Why?
|
| Hematocrit | 2 | 1991 | 623 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 737 | 0.020 |
Why?
|
| Injections | 1 | 1994 | 832 | 0.020 |
Why?
|
| Triglycerides | 4 | 1985 | 2459 | 0.020 |
Why?
|
| Azacitidine | 1 | 2012 | 335 | 0.020 |
Why?
|
| Program Evaluation | 2 | 2011 | 2486 | 0.020 |
Why?
|
| Device Removal | 1 | 2015 | 629 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 1739 | 0.020 |
Why?
|
| Corrosion Casting | 1 | 2009 | 15 | 0.020 |
Why?
|
| Microspheres | 1 | 1993 | 782 | 0.020 |
Why?
|
| Informed Consent | 1 | 2017 | 1007 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 9526 | 0.020 |
Why?
|
| Gastric Mucins | 1 | 2009 | 19 | 0.020 |
Why?
|
| Attitude to Health | 2 | 2003 | 2025 | 0.020 |
Why?
|
| Sound | 1 | 2012 | 257 | 0.020 |
Why?
|
| Endoscopy, Digestive System | 1 | 1993 | 353 | 0.020 |
Why?
|
| DNA Methylation | 2 | 2016 | 4392 | 0.020 |
Why?
|
| Magnesium | 2 | 1989 | 804 | 0.020 |
Why?
|
| Misonidazole | 2 | 1987 | 33 | 0.020 |
Why?
|
| Noise, Occupational | 1 | 2009 | 26 | 0.020 |
Why?
|
| Genotype | 3 | 2016 | 12977 | 0.020 |
Why?
|
| Sex | 1 | 2010 | 53 | 0.020 |
Why?
|
| Kinetics | 1 | 1998 | 6370 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 1992 | 379 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 1992 | 436 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2015 | 2063 | 0.020 |
Why?
|
| Lung | 4 | 2004 | 9999 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 3621 | 0.020 |
Why?
|
| Minority Groups | 1 | 2017 | 1202 | 0.020 |
Why?
|
| Light | 1 | 1996 | 1352 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2001 | 1914 | 0.020 |
Why?
|
| Asia | 1 | 2011 | 616 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 1991 | 186 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2012 | 443 | 0.020 |
Why?
|
| Cost Savings | 1 | 1995 | 912 | 0.020 |
Why?
|
| Cell Separation | 1 | 2015 | 1718 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 1995 | 937 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2012 | 481 | 0.020 |
Why?
|
| Certification | 1 | 1993 | 418 | 0.020 |
Why?
|
| Testis | 1 | 2012 | 792 | 0.020 |
Why?
|
| Antigens | 1 | 1974 | 1441 | 0.020 |
Why?
|
| Carcinoma | 3 | 1990 | 2328 | 0.020 |
Why?
|
| Isoelectric Focusing | 2 | 1979 | 150 | 0.020 |
Why?
|
| Glucagonoma | 1 | 2008 | 14 | 0.020 |
Why?
|
| Cystic Duct | 1 | 1988 | 18 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 1250 | 0.020 |
Why?
|
| Radionuclide Imaging | 2 | 1988 | 1972 | 0.020 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2012 | 645 | 0.020 |
Why?
|
| Pain Measurement | 1 | 1998 | 3546 | 0.020 |
Why?
|
| Stomach Neoplasms | 1 | 1998 | 1459 | 0.020 |
Why?
|
| Gastrointestinal Contents | 1 | 1988 | 42 | 0.020 |
Why?
|
| Comorbidity | 2 | 2015 | 10507 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2008 | 2851 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2012 | 634 | 0.020 |
Why?
|
| Psychometrics | 1 | 2017 | 3062 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 1997 | 1894 | 0.020 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 1988 | 86 | 0.020 |
Why?
|
| alpha-Fetoproteins | 2 | 2006 | 222 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 2008 | 1703 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 1994 | 1788 | 0.020 |
Why?
|
| Hospitalization | 2 | 2015 | 10708 | 0.020 |
Why?
|
| Duodenal Ulcer | 2 | 1980 | 121 | 0.020 |
Why?
|
| RNA Interference | 1 | 2016 | 2829 | 0.020 |
Why?
|
| Iohexol | 2 | 1999 | 204 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 1994 | 1263 | 0.020 |
Why?
|
| Policy Making | 1 | 2011 | 541 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1995 | 4010 | 0.020 |
Why?
|
| Genetic Markers | 3 | 1998 | 2601 | 0.020 |
Why?
|
| Hospitals | 1 | 2021 | 3879 | 0.020 |
Why?
|
| Salivary Glands | 3 | 1984 | 229 | 0.020 |
Why?
|
| Protein Binding | 2 | 2016 | 9345 | 0.020 |
Why?
|
| Feces | 2 | 1991 | 1490 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 876 | 0.020 |
Why?
|
| Immune System | 1 | 2012 | 791 | 0.020 |
Why?
|
| Metabolic Clearance Rate | 2 | 1979 | 361 | 0.020 |
Why?
|
| Blood Platelets | 3 | 1975 | 2478 | 0.020 |
Why?
|
| Logistic Models | 4 | 2007 | 13248 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2012 | 1008 | 0.020 |
Why?
|
| Bucrylate | 1 | 1986 | 6 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2013 | 1300 | 0.020 |
Why?
|
| Neuroimmunomodulation | 1 | 2008 | 184 | 0.020 |
Why?
|
| Cell Transdifferentiation | 1 | 2007 | 186 | 0.020 |
Why?
|
| Hyperparathyroidism | 1 | 1968 | 337 | 0.020 |
Why?
|
| Food | 1 | 1991 | 768 | 0.020 |
Why?
|
| Parathyroid Neoplasms | 1 | 1968 | 242 | 0.020 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 834 | 0.020 |
Why?
|
| Mississippi | 1 | 2006 | 94 | 0.020 |
Why?
|
| Bromthymol Blue | 1 | 1985 | 2 | 0.020 |
Why?
|
| Cell Division | 2 | 2003 | 4457 | 0.020 |
Why?
|
| Gene Expression | 1 | 2019 | 7569 | 0.020 |
Why?
|
| Hypothyroidism | 1 | 2011 | 668 | 0.020 |
Why?
|
| Venae Cavae | 2 | 1978 | 40 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2010 | 1068 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1973 | 2100 | 0.020 |
Why?
|
| Blood Volume | 2 | 1995 | 547 | 0.020 |
Why?
|
| Jejunal Diseases | 1 | 1985 | 46 | 0.020 |
Why?
|
| Ileal Diseases | 1 | 1985 | 68 | 0.020 |
Why?
|
| Oxidation-Reduction | 2 | 2002 | 2231 | 0.020 |
Why?
|
| Cytokines | 2 | 2012 | 7373 | 0.020 |
Why?
|
| Ifosfamide | 1 | 2006 | 232 | 0.020 |
Why?
|
| Gastroscopy | 1 | 1987 | 211 | 0.020 |
Why?
|
| Educational Status | 1 | 2013 | 2509 | 0.020 |
Why?
|
| Carrier State | 1 | 2009 | 522 | 0.020 |
Why?
|
| Rectal Fistula | 1 | 1985 | 75 | 0.020 |
Why?
|
| Staphylococcal Infections | 1 | 1994 | 1406 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1995 | 6305 | 0.020 |
Why?
|
| RNA | 1 | 2015 | 2713 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2008 | 749 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9644 | 0.020 |
Why?
|
| Medical Audit | 1 | 2006 | 453 | 0.020 |
Why?
|
| Vagotomy | 1 | 1985 | 83 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1985 | 306 | 0.020 |
Why?
|
| Tritium | 3 | 1974 | 706 | 0.020 |
Why?
|
| Age Factors | 2 | 2017 | 18381 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 5780 | 0.020 |
Why?
|
| Siblings | 1 | 2009 | 824 | 0.020 |
Why?
|
| Urinary Bladder | 1 | 1991 | 1151 | 0.020 |
Why?
|
| Neostigmine | 1 | 1985 | 68 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2005 | 151 | 0.020 |
Why?
|
| Splanchnic Circulation | 1 | 2005 | 119 | 0.020 |
Why?
|
| Streptococcal Infections | 1 | 1989 | 617 | 0.010 |
Why?
|
| Colloids | 2 | 1996 | 123 | 0.010 |
Why?
|
| Blood Cell Count | 2 | 1975 | 397 | 0.010 |
Why?
|
| Vinblastine | 1 | 2006 | 488 | 0.010 |
Why?
|
| Europe | 1 | 2011 | 3415 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1994 | 2495 | 0.010 |
Why?
|
| Thrombin | 1 | 1966 | 592 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 1993 | 2055 | 0.010 |
Why?
|
| Kernicterus | 1 | 1963 | 11 | 0.010 |
Why?
|
| Ileostomy | 1 | 1985 | 121 | 0.010 |
Why?
|
| Private Sector | 1 | 2007 | 394 | 0.010 |
Why?
|
| Burns | 1 | 1995 | 1875 | 0.010 |
Why?
|
| Transferases | 1 | 1963 | 72 | 0.010 |
Why?
|
| Gender Identity | 1 | 2010 | 765 | 0.010 |
Why?
|
| Medicaid | 1 | 2017 | 2814 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 642 | 0.010 |
Why?
|
| Anemia | 1 | 1993 | 1504 | 0.010 |
Why?
|
| Hyperbilirubinemia | 1 | 1963 | 74 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1973 | 1810 | 0.010 |
Why?
|
| Parenteral Nutrition | 1 | 2008 | 659 | 0.010 |
Why?
|
| Jaundice, Neonatal | 1 | 1963 | 71 | 0.010 |
Why?
|
| Operating Rooms | 1 | 2009 | 790 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 1985 | 527 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2012 | 2546 | 0.010 |
Why?
|
| Umbilical Veins | 1 | 2003 | 426 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1995 | 10754 | 0.010 |
Why?
|
| Genes, erbB-2 | 1 | 2003 | 162 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 2004 | 342 | 0.010 |
Why?
|
| Lymph | 2 | 1974 | 77 | 0.010 |
Why?
|
| Hormones | 1 | 1987 | 869 | 0.010 |
Why?
|
| Risk Management | 1 | 2006 | 557 | 0.010 |
Why?
|
| Permeability | 2 | 1997 | 721 | 0.010 |
Why?
|
| Staff Development | 1 | 2005 | 227 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2008 | 2278 | 0.010 |
Why?
|
| Haplorhini | 1 | 1963 | 525 | 0.010 |
Why?
|
| Blood Group Incompatibility | 1 | 1963 | 133 | 0.010 |
Why?
|
| Absorption | 1 | 2002 | 242 | 0.010 |
Why?
|
| Macromolecular Substances | 2 | 1978 | 1433 | 0.010 |
Why?
|
| Glycolysis | 1 | 1966 | 835 | 0.010 |
Why?
|
| Spectrum Analysis | 2 | 1994 | 452 | 0.010 |
Why?
|
| Safety | 1 | 2007 | 1149 | 0.010 |
Why?
|
| Alleles | 3 | 1998 | 6861 | 0.010 |
Why?
|
| Chromatography, Gel | 2 | 1974 | 645 | 0.010 |
Why?
|
| Homeostasis | 2 | 2008 | 3321 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1992 | 13442 | 0.010 |
Why?
|
| Age Distribution | 1 | 2008 | 2872 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1996 | 3527 | 0.010 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2002 | 111 | 0.010 |
Why?
|
| Benzamidines | 1 | 2001 | 20 | 0.010 |
Why?
|
| Gastric Juice | 1 | 1981 | 59 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1967 | 1172 | 0.010 |
Why?
|
| Hydrochloric Acid | 1 | 1981 | 76 | 0.010 |
Why?
|
| Sarcoma | 2 | 2010 | 1800 | 0.010 |
Why?
|
| Fluorometry | 1 | 2001 | 99 | 0.010 |
Why?
|
| Erythroblastosis, Fetal | 1 | 1962 | 62 | 0.010 |
Why?
|
| Hypoproteinemia | 2 | 1973 | 11 | 0.010 |
Why?
|
| Injections, Intra-Arterial | 1 | 2001 | 181 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1981 | 166 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 4058 | 0.010 |
Why?
|
| Pedigree | 1 | 2009 | 4539 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 1991 | 5863 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 1998 | 1333 | 0.010 |
Why?
|
| Multiple Endocrine Neoplasia | 1 | 2000 | 25 | 0.010 |
Why?
|
| Cholecystokinin | 1 | 2001 | 115 | 0.010 |
Why?
|
| Chromatography, Paper | 2 | 1973 | 76 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2016 | 14388 | 0.010 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 1 | 2000 | 43 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2008 | 1819 | 0.010 |
Why?
|
| Morphine | 1 | 1985 | 655 | 0.010 |
Why?
|
| Diet | 2 | 1994 | 8049 | 0.010 |
Why?
|
| Blood Group Antigens | 1 | 1962 | 182 | 0.010 |
Why?
|
| Actuarial Analysis | 2 | 1993 | 372 | 0.010 |
Why?
|
| Peritoneum | 1 | 2001 | 225 | 0.010 |
Why?
|
| Peptic Ulcer Perforation | 1 | 1980 | 22 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 8998 | 0.010 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2001 | 175 | 0.010 |
Why?
|
| Computer Simulation | 2 | 2009 | 6233 | 0.010 |
Why?
|
| Hospital Costs | 1 | 2006 | 947 | 0.010 |
Why?
|
| Cartilage | 1 | 2003 | 806 | 0.010 |
Why?
|
| Hysterectomy | 1 | 1985 | 856 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2011 | 2515 | 0.010 |
Why?
|
| Cisplatin | 1 | 2006 | 1650 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 1987 | 883 | 0.010 |
Why?
|
| Achlorhydria | 1 | 1979 | 9 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1973 | 458 | 0.010 |
Why?
|
| Galactosyltransferases | 1 | 1981 | 276 | 0.010 |
Why?
|
| Keratin-20 | 1 | 1999 | 31 | 0.010 |
Why?
|
| Decision Making | 1 | 1993 | 3919 | 0.010 |
Why?
|
| Chromogranin A | 1 | 1999 | 47 | 0.010 |
Why?
|
| Acyltransferases | 1 | 2001 | 305 | 0.010 |
Why?
|
| Candida albicans | 1 | 1982 | 372 | 0.010 |
Why?
|
| Anemia, Hypochromic | 1 | 1979 | 63 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 1999 | 138 | 0.010 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1984 | 745 | 0.010 |
Why?
|
| Leukocyte Count | 2 | 1974 | 1597 | 0.010 |
Why?
|
| Detergents | 1 | 1999 | 236 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 1979 | 88 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 1992 | 2492 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 17630 | 0.010 |
Why?
|
| Manganese | 1 | 2002 | 393 | 0.010 |
Why?
|
| Therapeutic Irrigation | 1 | 1980 | 289 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12333 | 0.010 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1998 | 135 | 0.010 |
Why?
|
| Serum Globulins | 1 | 1978 | 23 | 0.010 |
Why?
|
| Portacaval Shunt, Surgical | 1 | 1978 | 46 | 0.010 |
Why?
|
| Physical Examination | 1 | 1984 | 1254 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1999 | 817 | 0.010 |
Why?
|
| Ovarian Neoplasms | 2 | 2010 | 4849 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2009 | 3606 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 3088 | 0.010 |
Why?
|
| Chromogranins | 1 | 1999 | 160 | 0.010 |
Why?
|
| Cyst Fluid | 1 | 1998 | 83 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 2003 | 825 | 0.010 |
Why?
|
| Intermediate Filament Proteins | 1 | 1999 | 262 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1985 | 2185 | 0.010 |
Why?
|
| Isothiocyanates | 1 | 1998 | 49 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1963 | 2669 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 22117 | 0.010 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 1997 | 18 | 0.010 |
Why?
|
| Salpingitis | 1 | 1977 | 11 | 0.010 |
Why?
|
| Keto Acids | 1 | 1977 | 35 | 0.010 |
Why?
|
| Sarcoma, Experimental | 1 | 1997 | 116 | 0.010 |
Why?
|
| Autoantigens | 1 | 1962 | 888 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1998 | 346 | 0.010 |
Why?
|
| Puromycin | 2 | 1967 | 42 | 0.010 |
Why?
|
| Inflammation | 2 | 2007 | 10759 | 0.010 |
Why?
|
| Lymphography | 1 | 1978 | 188 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1998 | 410 | 0.010 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1998 | 268 | 0.010 |
Why?
|
| Mesenteric Artery, Superior | 1 | 1997 | 96 | 0.010 |
Why?
|
| Hypertonic Solutions | 1 | 1996 | 82 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1963 | 2328 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1998 | 343 | 0.010 |
Why?
|
| Rectal Neoplasms | 1 | 1985 | 1156 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1997 | 777 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1997 | 416 | 0.010 |
Why?
|
| Anesthesia | 2 | 2004 | 1591 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2003 | 1349 | 0.010 |
Why?
|
| Tissue Polypeptide Antigen | 1 | 1996 | 4 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1997 | 767 | 0.010 |
Why?
|
| von Hippel-Lindau Disease | 1 | 1997 | 151 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 4028 | 0.010 |
Why?
|
| Fetus | 1 | 1963 | 1862 | 0.010 |
Why?
|
| Ketones | 1 | 1977 | 183 | 0.010 |
Why?
|
| Phlebography | 1 | 1997 | 326 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1998 | 699 | 0.010 |
Why?
|
| Image Cytometry | 1 | 1996 | 54 | 0.010 |
Why?
|
| Gastrins | 1 | 1975 | 75 | 0.010 |
Why?
|
| Alcoholism | 2 | 1984 | 1972 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1975 | 184 | 0.010 |
Why?
|
| Swine | 1 | 2005 | 5908 | 0.010 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 1997 | 304 | 0.010 |
Why?
|
| Exercise | 1 | 2012 | 5886 | 0.010 |
Why?
|
| Veins | 1 | 1999 | 767 | 0.010 |
Why?
|
| Fibrosarcoma | 1 | 1997 | 308 | 0.010 |
Why?
|
| Ploidies | 1 | 1996 | 285 | 0.010 |
Why?
|
| Smoke Inhalation Injury | 1 | 1995 | 47 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1962 | 1320 | 0.010 |
Why?
|
| Mesenteric Arteries | 2 | 1991 | 178 | 0.010 |
Why?
|
| Aortic Rupture | 1 | 1978 | 319 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1997 | 1301 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 1997 | 783 | 0.010 |
Why?
|
| Research | 1 | 1963 | 1977 | 0.010 |
Why?
|
| Body Surface Area | 1 | 1995 | 197 | 0.010 |
Why?
|
| Gadolinium | 1 | 2000 | 959 | 0.010 |
Why?
|
| Stomach Ulcer | 1 | 1975 | 122 | 0.010 |
Why?
|
| Sialadenitis | 1 | 1975 | 45 | 0.010 |
Why?
|
| Health Status | 1 | 2008 | 4076 | 0.010 |
Why?
|
| Electrophoresis, Starch Gel | 1 | 1974 | 19 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 1970 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2012 | 10175 | 0.010 |
Why?
|
| Immunodiffusion | 1 | 1974 | 141 | 0.010 |
Why?
|
| Amylose | 1 | 1974 | 3 | 0.010 |
Why?
|
| Iopamidol | 1 | 1995 | 186 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 1976 | 449 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2001 | 1340 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1994 | 397 | 0.010 |
Why?
|
| Phosphorus | 1 | 1975 | 332 | 0.010 |
Why?
|
| Salicylates | 1 | 1974 | 127 | 0.010 |
Why?
|
| Fatty Liver | 1 | 2000 | 787 | 0.010 |
Why?
|
| Abetalipoproteinemia | 1 | 1973 | 16 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 1978 | 648 | 0.010 |
Why?
|
| Remission, Spontaneous | 1 | 1974 | 384 | 0.010 |
Why?
|
| Whipple Disease | 1 | 1973 | 20 | 0.010 |
Why?
|
| Glucagon | 1 | 1975 | 531 | 0.010 |
Why?
|
| Electrons | 2 | 1984 | 265 | 0.010 |
Why?
|
| Blood Gas Analysis | 1 | 1994 | 379 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 26065 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1974 | 165 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 2009 | 26183 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 12759 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 1985 | 4408 | 0.010 |
Why?
|
| Splenic Infarction | 1 | 1972 | 12 | 0.010 |
Why?
|
| Splenic Rupture | 1 | 1972 | 26 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1977 | 1148 | 0.010 |
Why?
|
| Multiple Trauma | 1 | 1995 | 369 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2004 | 3567 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 4533 | 0.010 |
Why?
|
| Celiac Disease | 2 | 1973 | 819 | 0.010 |
Why?
|
| Gallbladder | 1 | 1974 | 308 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6126 | 0.010 |
Why?
|
| Celiac Artery | 1 | 1972 | 65 | 0.010 |
Why?
|
| Hemostasis | 1 | 1975 | 469 | 0.010 |
Why?
|
| Insulin | 1 | 1987 | 6593 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1973 | 362 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 2 | 1978 | 951 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1992 | 397 | 0.010 |
Why?
|
| Technetium | 1 | 1972 | 317 | 0.010 |
Why?
|
| Aneuploidy | 1 | 1996 | 552 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1979 | 20988 | 0.010 |
Why?
|
| Melanoma | 1 | 2010 | 5696 | 0.010 |
Why?
|
| Foreign-Body Reaction | 1 | 1972 | 157 | 0.010 |
Why?
|
| Portal System | 1 | 1971 | 49 | 0.010 |
Why?
|
| Sulfur | 1 | 1972 | 161 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2001 | 2894 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 4172 | 0.010 |
Why?
|
| Drug Monitoring | 1 | 1998 | 960 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1971 | 326 | 0.010 |
Why?
|
| Emergencies | 1 | 1978 | 1217 | 0.010 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 1996 | 473 | 0.010 |
Why?
|
| Positive-Pressure Respiration | 1 | 1975 | 638 | 0.010 |
Why?
|
| Chlorides | 1 | 1974 | 665 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2001 | 6339 | 0.010 |
Why?
|
| Diarrhea | 2 | 1968 | 1317 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1998 | 1932 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 1975 | 1683 | 0.010 |
Why?
|
| Punctures | 1 | 1992 | 364 | 0.010 |
Why?
|
| Child, Preschool | 3 | 1991 | 42193 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 1974 | 538 | 0.010 |
Why?
|
| Cecum | 2 | 1984 | 233 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 17878 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1973 | 625 | 0.010 |
Why?
|
| Bile Acids and Salts | 1 | 1992 | 393 | 0.010 |
Why?
|
| Biological Transport | 1 | 1974 | 2089 | 0.010 |
Why?
|
| Hepatic Artery | 1 | 1991 | 232 | 0.010 |
Why?
|
| Microscopy | 1 | 1994 | 905 | 0.010 |
Why?
|
| Particle Size | 1 | 1993 | 1648 | 0.010 |
Why?
|
| Phenolphthaleins | 1 | 1968 | 5 | 0.000 |
Why?
|
| Parathyroid Hormone | 1 | 1975 | 1803 | 0.000 |
Why?
|
| Abdominal Injuries | 1 | 1971 | 360 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1998 | 2410 | 0.000 |
Why?
|
| Skin | 1 | 2002 | 4472 | 0.000 |
Why?
|
| Enteral Nutrition | 1 | 1974 | 794 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1976 | 2174 | 0.000 |
Why?
|
| Angiokeratoma | 1 | 1967 | 5 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1974 | 1438 | 0.000 |
Why?
|
| Apoptosis | 1 | 2003 | 9476 | 0.000 |
Why?
|
| Orotic Acid | 1 | 1966 | 24 | 0.000 |
Why?
|
| Polyethylene Glycols | 1 | 1993 | 1182 | 0.000 |
Why?
|
| Cathartics | 1 | 1968 | 127 | 0.000 |
Why?
|
| Dactinomycin | 1 | 1967 | 304 | 0.000 |
Why?
|
| Brachytherapy | 2 | 1984 | 1223 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 12143 | 0.000 |
Why?
|
| Mannose | 1 | 1966 | 121 | 0.000 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 1967 | 123 | 0.000 |
Why?
|
| Glycolipids | 1 | 1967 | 206 | 0.000 |
Why?
|
| Lithostathine | 1 | 1985 | 5 | 0.000 |
Why?
|
| Liver Function Tests | 1 | 1968 | 524 | 0.000 |
Why?
|
| Self Administration | 1 | 1987 | 387 | 0.000 |
Why?
|
| Base Sequence | 1 | 1997 | 12420 | 0.000 |
Why?
|
| Galactose | 1 | 1966 | 294 | 0.000 |
Why?
|
| Liver Cirrhosis | 1 | 1976 | 1927 | 0.000 |
Why?
|
| Radioimmunoassay | 1 | 1985 | 861 | 0.000 |
Why?
|
| Lipid Metabolism | 1 | 1973 | 1896 | 0.000 |
Why?
|
| Fructose | 1 | 1966 | 288 | 0.000 |
Why?
|
| Digestive System Neoplasms | 1 | 1985 | 83 | 0.000 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1985 | 149 | 0.000 |
Why?
|
| Solubility | 1 | 1985 | 1089 | 0.000 |
Why?
|
| Leukocytosis | 1 | 1985 | 251 | 0.000 |
Why?
|
| Radiation, Ionizing | 1 | 1984 | 251 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1977 | 3842 | 0.000 |
Why?
|
| Adenoma, Bile Duct | 1 | 1982 | 29 | 0.000 |
Why?
|
| DNA | 1 | 1997 | 7196 | 0.000 |
Why?
|
| Blood Glucose | 1 | 1977 | 6390 | 0.000 |
Why?
|
| Complement C1 | 1 | 1981 | 31 | 0.000 |
Why?
|
| Barium Sulfate | 1 | 1981 | 180 | 0.000 |
Why?
|
| Calcium-Binding Proteins | 1 | 1985 | 1066 | 0.000 |
Why?
|
| Amino Acids | 1 | 1985 | 1718 | 0.000 |
Why?
|
| Genital Neoplasms, Female | 1 | 1985 | 532 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1981 | 509 | 0.000 |
Why?
|
| Intestinal Diseases | 1 | 1984 | 503 | 0.000 |
Why?
|
| Serologic Tests | 1 | 1981 | 381 | 0.000 |
Why?
|
| Ferritins | 1 | 1981 | 597 | 0.000 |
Why?
|
| Polyethylene Terephthalates | 1 | 1978 | 112 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1985 | 3965 | 0.000 |
Why?
|
| Lipids | 1 | 1968 | 3332 | 0.000 |
Why?
|
| Pregnancy | 1 | 1977 | 29869 | 0.000 |
Why?
|
| Hemothorax | 1 | 1975 | 57 | 0.000 |
Why?
|
| Prothrombin Time | 1 | 1975 | 117 | 0.000 |
Why?
|
| Chloramphenicol | 1 | 1974 | 67 | 0.000 |
Why?
|
| Tachycardia | 1 | 1977 | 597 | 0.000 |
Why?
|
| Pulmonary Atelectasis | 1 | 1975 | 143 | 0.000 |
Why?
|
| Methylprednisolone | 1 | 1974 | 385 | 0.000 |
Why?
|
| Equipment and Supplies | 1 | 1975 | 273 | 0.000 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1985 | 2223 | 0.000 |
Why?
|
| Pressure | 1 | 1975 | 1150 | 0.000 |
Why?
|
| Blood Coagulation Disorders | 1 | 1975 | 350 | 0.000 |
Why?
|
| Penicillins | 1 | 1974 | 402 | 0.000 |
Why?
|
| Shock, Septic | 1 | 1977 | 769 | 0.000 |
Why?
|
| Vascular Diseases | 1 | 1977 | 1159 | 0.000 |
Why?
|
| Chromium Isotopes | 1 | 1968 | 28 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1977 | 1230 | 0.000 |
Why?
|
| Hypernatremia | 1 | 1968 | 78 | 0.000 |
Why?
|
| Hypokalemia | 1 | 1968 | 153 | 0.000 |
Why?
|
| Enzymes | 1 | 1967 | 257 | 0.000 |
Why?
|
| Albumins | 1 | 1968 | 575 | 0.000 |
Why?
|
| Heart Arrest | 1 | 1975 | 1513 | 0.000 |
Why?
|
| Acute Kidney Injury | 1 | 1977 | 1923 | 0.000 |
Why?
|
| Phenols | 1 | 1968 | 516 | 0.000 |
Why?
|
| Albuminuria | 1 | 1968 | 655 | 0.000 |
Why?
|
| Pyridines | 1 | 1968 | 2875 | 0.000 |
Why?
|
| Substance-Related Disorders | 1 | 1968 | 4416 | 0.000 |
Why?
|